Diabetes drug can prevent heart disease

March 26, 2012

The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy, at the University of Gothenburg, Sweden.

Researchers at the University of Gothenburg's Sahlgrenska Academy have shown in a preliminary study in rats that one of the most common diabetes drugs, metformin, also has a protective effect on the heart.

The study, carried out in collaboration with a research group from Naples and published in the journal Diabetes, reveals that metformin helps increase pumping capacity, improve , reduce the accumulation of fat, and limit the loss of through .

Long term effect

The results were compared with animals treated with another diabetes drug, which proved to have no positive effects on the heart. "The animals in our study were treated with metformin for a whole year, so the effect seems to persist," says Jörgen Isgaard, the researcher at the Sahlgrenska Academy who led the Swedish research group involved in the study.

New study on patients

have proved to have a number of serious side-effects for people with heart disease. Rosiglitazone, for example, was recently withdrawn due to its cardiac side-effects. Metformin too can occasionally have side-effects, primarily in patients with kidney failure. "Our results nevertheless strengthen the indication for as a diabetes medicine, and we hope that they are now followed up with studies on actual patients," says Isgaard.

Explore further: Rosiglitazone does not harm bone healing if combined with metformin in rats

More information: The article Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model was published in Diabetes on 22 February.

Related Stories

Recommended for you

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.